BOCCUTO, ADELE
 Distribuzione geografica
Continente #
EU - Europa 1.523
NA - Nord America 1.397
AS - Asia 132
SA - Sud America 3
Continente sconosciuto - Info sul continente non disponibili 1
OC - Oceania 1
Totale 3.057
Nazione #
US - Stati Uniti d'America 1.393
GB - Regno Unito 446
IE - Irlanda 334
IT - Italia 306
SE - Svezia 163
FR - Francia 91
CN - Cina 75
DE - Germania 48
UA - Ucraina 45
FI - Finlandia 26
ES - Italia 25
IN - India 23
BE - Belgio 17
IR - Iran 9
TR - Turchia 9
VN - Vietnam 7
GR - Grecia 6
RU - Federazione Russa 5
CA - Canada 3
PL - Polonia 3
BR - Brasile 2
HK - Hong Kong 2
JP - Giappone 2
NL - Olanda 2
AR - Argentina 1
AU - Australia 1
BY - Bielorussia 1
CH - Svizzera 1
CY - Cipro 1
CZ - Repubblica Ceca 1
DK - Danimarca 1
EU - Europa 1
KR - Corea 1
LT - Lituania 1
PA - Panama 1
RO - Romania 1
SG - Singapore 1
TH - Thailandia 1
UZ - Uzbekistan 1
Totale 3.057
Città #
Southend 424
Dublin 330
Fairfield 223
Chandler 219
Siena 109
Ashburn 91
Seattle 83
Woodbridge 80
Ann Arbor 73
Cambridge 72
Houston 71
Wilmington 62
Princeton 56
Jacksonville 39
New York 37
Beijing 32
Helsinki 25
Málaga 23
Rome 23
San Diego 19
Brussels 17
San Mateo 16
Shanghai 13
Dearborn 12
Redwood City 10
Boardman 9
Fremont 9
Nanjing 8
Dong Ket 7
Roccagorga 7
Izmir 6
London 6
Milan 6
Paris 6
Andover 5
Brescia 5
Florence 5
Zanjan 5
Bangalore 4
Cagliari 4
Leawood 4
Naples 4
Pavia 4
Saint-Fons 4
Kilburn 3
Mumbai 3
Padova 3
Parma 3
Taranto 3
Toronto 3
Amsterdam 2
Carmignano 2
Chiswick 2
Chongqing 2
Esslingen am Neckar 2
Foggia 2
Frankfurt am Main 2
Haikou 2
Hebei 2
Hyderabad 2
Jiaxing 2
Jinan 2
Kashan 2
Kocaeli 2
Nanchang 2
Napoli 2
Ningbo 2
Orangeburg 2
Redmond 2
Romainville 2
Scandicci 2
Strigno 2
Tianjin 2
Viterbo 2
Acton 1
Adana 1
Afragola 1
Agrigento 1
Alcorcón 1
Alezio 1
Alghero 1
Antea 1
Avellino 1
Bangkok 1
Bari 1
Briey 1
Canberra 1
Casole d'Elsa 1
Castelvetrano 1
Changsha 1
Cosenza 1
Council Bluffs 1
Falkenstein 1
Frederiksberg 1
Grosseto 1
Guangzhou 1
Guidonia Montecelio 1
Heidelberg 1
Hounslow 1
Islington 1
Totale 2.359
Nome #
The HIV-1 reverse transcriptase E138A natural polymorphism decreases the genetic barrier to resistance to etravirine in vitro 209
Comparable in vitro activity of second-generation HIV-1 integrase strand transfer inhibitors (INSTIs) on HIV-1 clinical isolates with INSTI resistance mutations 192
Agreement between an in-house replication competent and a reference replication defective recombinant virus assay for measuring phenotypic resistance to HIV-1 protease, reverse transcriptase, and integrase inhibitors 180
Maraviroc as a potential HIV-1 latency-reversing agent in cell line models and ex vivo CD4 T cells 157
DDX3X inhibitors, an effective way to overcome HIV-1 resistance 152
The HIV-1 integrase E157Q polymorphism per se does not alter susceptibility to raltegravir and dolutegravir in vitro 148
Comparative analysis of different cell systems for Zika virus (ZIKV) propagation and evaluation of anti-ZIKV compounds in vitro 145
Synthesis and Antiviral Activity of Novel 1,3,4-Thiadiazole Inhibitors of DDX3X 145
Development of an internally controlled quantitative PCR to measure total cell-associated HIV-1 DNA in blood 144
Performance of Geno2Pheno[coreceptor] to infer coreceptor use in human immunodeficiency virus type 1 (HIV-1) subtype A 135
Evaluation of sofosbuvir activity and resistance profile against West Nile virus in vitro. 117
System-oriented optimization of multi-target 2,6-diaminopurine derivatives: Easily accessible broad-spectrum antivirals active against flaviviruses, influenza virus and SARS-CoV-2 116
Exploring the implication of DDX3X in DENV infection: discovery of the first-in-class DDX3X fluorescent inhibitor 114
In vitro cross-resistance to doravirine in a panel of HIV-1 clones harbouring multiple NNRTI resistance mutations 107
Development of a Cell-Based Immunodetection Assay for Simultaneous Screening of Antiviral Compounds Inhibiting Zika and Dengue Virus Replication. 103
Zika virus in west africa: A seroepidemiological study between 2007 and 2012 94
The second dose of the BNT162b2 mRNA vaccine does not boost SARS-CoV-2 neutralizing antibody response in previously infected subjects 86
Bithiazole Inhibitors of Phosphatidylinositol 4-Kinase (PI4KIIIβ) as Broad-Spectrum Antivirals Blocking the Replication of SARS-CoV-2, Zika Virus and Human Rhinoviruses 84
Faster decay of neutralizing antibodies in never infected than previously infected healthcare workers three months after the second BNT162b2 mRNA COVID-19 vaccine dose 82
Unique Domain for a Unique Target: Selective Inhibitors of Host Cell DDX3X to Fight Emerging Viruses 79
Novel antiviral strategies against emerging viral diseases 74
Decreased neutralization of the Eta SARS-CoV-2 variant by sera of previously infected and uninfected vaccinated individuals 63
Single-dose BNT162b2 mRNA COVID-19 vaccine significantly boosts neutralizing antibody response in health care workers recovering from asymptomatic or mild natural SARS-CoV-2 infection 56
Neutralizing activity of African lineage Zika virus immune sera towards Asian lineage 52
Sofosbuvir selects for drug-resistant amino acid variants in the zika virus RNA-dependent RNA-polymerase complex in vitro 51
BNT162b2 SARS-CoV-2 vaccination elicits high titers of neutralizing antibodies to both b.1 and p.1 variants in previously infected and uninfected subjects 48
In vitro anti-sars-cov-2 activity of selected metal compounds and potential molecular basis for their actions based on computational study 48
SARS-CoV-2 Infection of Human Ovarian Cells: A Potential Negative Impact on Female Fertility 46
In vitro susceptibility of HIV-1 CRF02_AG to temsavir, the active compound of the attachment inhibitor fostemsavir 39
Time Course of Neutralizing Antibody in Health Care Workers With Mild or Asymptomatic COVID-19 Infection 34
null 32
Piperazine-derived small molecules as potential Flaviviridae NS3 protease inhibitors. In vitro antiviral activity evaluation against Zika and Dengue viruses 16
null 12
Totale 3.160
Categoria #
all - tutte 11.657
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 11.657


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201969 0 0 0 0 0 0 0 0 0 0 38 31
2019/2020492 23 18 73 44 36 39 43 43 41 64 28 40
2020/2021574 20 31 17 80 63 64 65 60 58 58 22 36
2021/2022752 31 88 60 94 47 52 44 53 37 60 65 121
2022/2023674 43 113 80 67 51 112 34 39 54 35 30 16
2023/2024510 18 18 53 33 13 161 186 10 0 18 0 0
Totale 3.160